NASDAQ:INMD InMode - INMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. $30.03 -0.38 (-1.25%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$29.47▼$30.6150-Day Range$29.72▼$41.4552-Week Range$20.60▼$41.84Volume1.01 million shsAverage Volume1.63 million shsMarket Capitalization$2.49 billionP/E Ratio15.81Dividend YieldN/APrice Target$46.33 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesShort InterestSocial Media InMode MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside54.3% Upside$46.33 Price TargetShort InterestBearish5.79% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 3 Articles This WeekInsider TradingN/AProj. Earnings Growth17.75%From $2.31 to $2.72 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.37 out of 5 starsMedical Sector231st out of 989 stocksElectromedical Equipment Industry2nd out of 24 stocks 3.4 Analyst's Opinion Consensus RatingInMode has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $46.33, InMode has a forecasted upside of 54.3% from its current price of $30.03.Amount of Analyst CoverageInMode has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.79% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InMode has recently increased by 7.37%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INMD. Previous Next 2.0 News and Social Media Coverage News SentimentInMode has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for InMode this week, compared to 4 articles on an average week.Search InterestOnly 86 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -26% compared to the previous 30 days.MarketBeat FollowsOnly 14 people have added InMode to their MarketBeat watchlist in the last 30 days. This is a decrease of -22% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions55.24% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for InMode are expected to grow by 17.75% in the coming year, from $2.31 to $2.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 15.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 118.09.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 15.81, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 124.16.Price to Book Value per Share RatioInMode has a P/B Ratio of 4.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About InMode (NASDAQ:INMD) StockInMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address INMD Stock News HeadlinesMarch 20, 2023 | finance.yahoo.comInMode's (NASDAQ:INMD) three-year total shareholder returns outpace the underlying earnings growthMarch 13, 2023 | finance.yahoo.comInMode Updates It Does Not Hold Cash Deposits at SVBMarch 24, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.March 2, 2023 | finance.yahoo.comInMode to Present In-Person at the Barclays Global Health ConferenceMarch 2, 2023 | finance.yahoo.comDon't Miss Out on These 2 Undervalued Stocks With Huge Growth PotentialFebruary 17, 2023 | finance.yahoo.comAnalyst Says M&A Could Be A Negative Catalyst For This Aesthetic CompanyFebruary 15, 2023 | finance.yahoo.comInMode Ltd. (NASDAQ:INMD) Q4 2022 Earnings Call TranscriptFebruary 15, 2023 | finance.yahoo.comInMode Full Year 2022 Earnings: EPS Misses ExpectationsMarch 24, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.February 14, 2023 | finance.yahoo.comInMode Reports Fourth Quarter and Full Year 2022 Financial Results; Record Quarterly Revenue of $133.6M Represents 21% Year-Over-Year GrowthFebruary 14, 2023 | finance.yahoo.comInMode's Q4 Earnings Surpass Expectations, Issues Mixed FY23 GuidanceFebruary 14, 2023 | finance.yahoo.comInMode Jumps Despite Mixed 2023 Outlook, But Uncertainty Continues For MedpaceFebruary 8, 2023 | finance.yahoo.comInMode Ltd. (NASDAQ:INMD) is a favorite amongst institutional investors who own 57%January 30, 2023 | finance.yahoo.comMedtech Stock Could Conquer Long-Term ResistanceJanuary 27, 2023 | finance.yahoo.com3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023January 25, 2023 | finance.yahoo.comWith EPS Growth And More, InMode (NASDAQ:INMD) Makes An Interesting CaseJanuary 20, 2023 | finance.yahoo.comInMode Stock: Bull vs. BearJanuary 16, 2023 | finance.yahoo.comBuy Shares of This Supercharged Growth Stock Today to Beat the Market in 2023January 11, 2023 | finance.yahoo.comInMode Stock Dropped 9% TodayJanuary 11, 2023 | finance.yahoo.comIs There An Opportunity With InMode Ltd.'s (NASDAQ:INMD) 41% Undervaluation?January 11, 2023 | finance.yahoo.comInMode Expects Record Fourth Quarter & Full Year 2022 Financial Results, Q4 Revenue Between $133.2M-$133.4MJanuary 3, 2023 | finance.yahoo.comInMode to Present at the 25th Annual Needham Growth ConferenceDecember 26, 2022 | finance.yahoo.comInMode Ltd.'s (NASDAQ:INMD) Stock Is Going Strong: Is the Market Following Fundamentals?December 13, 2022 | seekingalpha.comWhy InMode Deserves A Spot In Your 2023 PortfolioNovember 23, 2022 | finance.yahoo.comIs InMode Stock a Buy Now?November 16, 2022 | finance.yahoo.comUp 58% in 6 Months, Is InMode Stock Still a Bargain Buy?November 10, 2022 | finance.yahoo.comGet Into This Growth Stock for 2023 and BeyondSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address INMD Company Calendar Last Earnings10/26/2021Today3/24/2023Next Earnings (Estimated)5/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees362Year Founded2008Price Target and Rating Average Stock Price Forecast$46.33 High Stock Price Forecast$60.00 Low Stock Price Forecast$40.00 Forecasted Upside/Downside+55.3%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$1.90 Trailing P/E Ratio15.70 Forward P/E Ratio12.91 P/E GrowthN/ANet Income$161.52 million Net Margins35.56% Pretax Margin44.35% Return on Equity38.15% Return on Assets33.11% Debt Debt-to-Equity RatioN/A Current Ratio7.67 Quick Ratio7.19 Sales & Book Value Annual Sales$454.27 million Price / Sales5.45 Cash Flow$2.09 per share Price / Cash Flow14.29 Book Value$6.68 per share Price / Book4.47Miscellaneous Outstanding Shares83,070,000Free Float77,322,000Market Cap$2.48 billion OptionableNot Optionable Beta2.11 Social Links Key ExecutivesMr. Yair Malca (Age 45)Chief Financial Officer Comp: $525kMr. Alon YaariVP of OperationsMs. Nava Tal-LaunerChief Information OfficerMr. Shakil Lakhani (Age 40)Pres of North America Comp: $2.67MDr. Spero Theodorou M.D. (Age 51)Chief Medical Officer Comp: $1.84MMr. Moshe Mizrahy (Age 70)Chairman & CEO Dr. Michael Kreindel (Age 55)CTO & Director More ExecutivesKey CompetitorsIntegerNYSE:ITGRTransMedics GroupNASDAQ:TMDXLivaNovaNASDAQ:LIVNCONMEDNYSE:CNMDOutset MedicalNASDAQ:OMView All CompetitorsInstitutional OwnershipB. Riley Wealth Advisors Inc.Bought 8,261 shares on 3/15/2023Ownership: 0.010%Victory Capital Management Inc.Bought 98,378 shares on 3/10/2023Ownership: 0.888%Rockefeller Capital Management L.P.Bought 782 shares on 3/6/2023Ownership: 0.072%B. Riley Wealth Advisors Inc.Bought 8,261 shares on 2/21/2023Ownership: 0.010%Alliancebernstein L.P.Sold 6,514 shares on 2/16/2023Ownership: 0.018%View All Institutional Transactions INMD Stock - Frequently Asked Questions Should I buy or sell InMode stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INMD shares. View INMD analyst ratings or view top-rated stocks. What is InMode's stock price forecast for 2023? 5 Wall Street research analysts have issued 12 month target prices for InMode's stock. Their INMD share price forecasts range from $40.00 to $60.00. On average, they anticipate the company's stock price to reach $46.33 in the next twelve months. This suggests a possible upside of 55.3% from the stock's current price. View analysts price targets for INMD or view top-rated stocks among Wall Street analysts. How have INMD shares performed in 2023? InMode's stock was trading at $35.70 on January 1st, 2023. Since then, INMD stock has decreased by 16.4% and is now trading at $29.83. View the best growth stocks for 2023 here. Are investors shorting InMode? InMode saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 4,810,000 shares, an increase of 7.4% from the February 13th total of 4,480,000 shares. Based on an average daily volume of 1,440,000 shares, the days-to-cover ratio is presently 3.3 days. View InMode's Short Interest. When is InMode's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023. View our INMD earnings forecast. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) released its quarterly earnings results on Tuesday, October, 26th. The healthcare company reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.05. The healthcare company earned $94.18 million during the quarter, compared to analysts' expectations of $89.38 million. InMode had a trailing twelve-month return on equity of 38.15% and a net margin of 35.56%. InMode's quarterly revenue was up 57.7% on a year-over-year basis. During the same period last year, the company posted $0.31 earnings per share. What ETFs hold InMode's stock? ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include BlueStar Israel Technology ETF (ITEQ), ARK Israel Innovative Technology ETF (IZRL), iShares MSCI Israel ETF (EIS), VanEck Israel ETF (ISRA) and BlackRock Future Innovators ETF (BFTR).Vident International Equity Strategy ETF (VIDI). When did InMode's stock split? InMode's stock split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were issued to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What guidance has InMode issued on next quarter's earnings? InMode updated its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided earnings per share (EPS) guidance of $2.58-$2.60 for the period, compared to the consensus estimate of $2.64. The company issued revenue guidance of $525.00 million-$530.00 million, compared to the consensus revenue estimate of $522.72 million. What is Moshe Mizrahy's approval rating as InMode's CEO? 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL). When did InMode IPO? (INMD) raised $75 million in an initial public offering on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager. What is InMode's stock symbol? InMode trades on the NASDAQ under the ticker symbol "INMD." Who are InMode's major shareholders? InMode's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (2.67%), Millennium Management LLC (2.30%), American Century Companies Inc. (1.85%), William Blair Investment Management LLC (1.73%), Meitav Dash Investments Ltd. (1.34%) and Man Group plc (1.10%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is InMode's stock price today? One share of INMD stock can currently be purchased for approximately $29.83. How much money does InMode make? InMode (NASDAQ:INMD) has a market capitalization of $2.48 billion and generates $454.27 million in revenue each year. The healthcare company earns $161.52 million in net income (profit) each year or $1.90 on an earnings per share basis. How many employees does InMode have? The company employs 362 workers across the globe. Does InMode have any subsidiaries? The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..Read More How can I contact InMode? InMode's mailing address is TAVOR BUILDING SHAAR YOKNEAM POB 533, YOKNEAM L3, 2069200. The official website for the company is www.inmodemd.com. The healthcare company can be reached via phone at 972-4909-7470 or via email at ir@inmodemd.com. This page (NASDAQ:INMD) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.